1. Home
  2. IMUX vs RFM Comparison

IMUX vs RFM Comparison

Compare IMUX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • RFM
  • Stock Information
  • Founded
  • IMUX 2016
  • RFM 2020
  • Country
  • IMUX United States
  • RFM United States
  • Employees
  • IMUX N/A
  • RFM N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • RFM Finance/Investors Services
  • Sector
  • IMUX Health Care
  • RFM Finance
  • Exchange
  • IMUX Nasdaq
  • RFM Nasdaq
  • Market Cap
  • IMUX 86.3M
  • RFM 92.3M
  • IPO Year
  • IMUX N/A
  • RFM N/A
  • Fundamental
  • Price
  • IMUX $0.98
  • RFM $15.61
  • Analyst Decision
  • IMUX Strong Buy
  • RFM
  • Analyst Count
  • IMUX 6
  • RFM 0
  • Target Price
  • IMUX $12.67
  • RFM N/A
  • AVG Volume (30 Days)
  • IMUX 1.0M
  • RFM 20.7K
  • Earning Date
  • IMUX 02-20-2025
  • RFM 01-01-0001
  • Dividend Yield
  • IMUX N/A
  • RFM 9.74%
  • EPS Growth
  • IMUX N/A
  • RFM N/A
  • EPS
  • IMUX N/A
  • RFM N/A
  • Revenue
  • IMUX N/A
  • RFM N/A
  • Revenue This Year
  • IMUX N/A
  • RFM N/A
  • Revenue Next Year
  • IMUX N/A
  • RFM N/A
  • P/E Ratio
  • IMUX N/A
  • RFM N/A
  • Revenue Growth
  • IMUX N/A
  • RFM N/A
  • 52 Week Low
  • IMUX $0.92
  • RFM $12.89
  • 52 Week High
  • IMUX $2.11
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 44.34
  • RFM 65.66
  • Support Level
  • IMUX $0.94
  • RFM $15.24
  • Resistance Level
  • IMUX $1.02
  • RFM $15.60
  • Average True Range (ATR)
  • IMUX 0.06
  • RFM 0.07
  • MACD
  • IMUX 0.00
  • RFM 0.05
  • Stochastic Oscillator
  • IMUX 44.96
  • RFM 99.98

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: